| 000 | 01195 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250513054734.0 | ||
| 264 | 0 | _c19940728 | |
| 008 | 199407s 0 0 eng d | ||
| 022 | _a0364-5134 | ||
| 024 | 7 |
_a10.1002/ana.410360726 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPaty, D W | |
| 245 | 0 | 0 |
_aThe interferon-beta 1b clinical trial and its implications for other trials. _h[electronic resource] |
| 260 |
_bAnnals of neurology _c1994 |
||
| 300 |
_aS113-4 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article | ||
| 650 | 0 | 4 |
_aBrain _xpathology |
| 650 | 0 | 4 |
_aClinical Trials as Topic _xmethods |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInterferon beta-1a |
| 650 | 0 | 4 | _aInterferon beta-1b |
| 650 | 0 | 4 |
_aInterferon-beta _xtherapeutic use |
| 650 | 0 | 4 | _aMagnetic Resonance Imaging |
| 650 | 0 | 4 |
_aMultiple Sclerosis _xpathology |
| 650 | 0 | 4 | _aPlacebos |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 | _aResearch Design |
| 650 | 0 | 4 | _aTreatment Outcome |
| 773 | 0 |
_tAnnals of neurology _gvol. 36 Suppl _gp. S113-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/ana.410360726 _zAvailable from publisher's website |
| 999 |
_c8017193 _d8017193 |
||